Diabetes Medications

Crédito

Volantes

Altavoz

Tracey Long, PhD, MS, MSN, RN, APRN-BC, CDCES, CCRN, CNE, COI Related seminars and products

---

Tracey Long, PhD, MS, MSN, RN, APRN-BC, CDCES, CCRN, CNE, COI, has worked as a Family Nurse Practitioner in endocrinology, critical care, and primary care, earning degrees from Brigham Young University, Purdue University and UNLV. Dr. Long is a critical care clinical instructor, a Certified Diabetes Care and Education Specialist, has developed diabetes education programs and teaches a diabetes educator certification course. She has a passion for active learning and is an international speaker and award-winning educator.
 

Speaker Disclosures:
Financial: Tracey Long has employment relationships with Utah Body and Soul, College of Southern Nevada, Chamberlain College, Travelers Education Group, Nurse.Com, and Atrain. She receives compensation as a freelance writer and editor. Tracey Long receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Tracey Long is a member of the American Association of Nurse Practitioners, the American Association of Critical Care Nurses, the American Diabetes Association, the National Certified Diabetes Educator Association, and the American Nurses Association. She is on the editorial board of the Journal of Medical Education Development and is a contributing editor Yangtz Journal of Medicine.

 

Información adicional

Información sobre el programa

El acceso a este producto no caduca nunca.

 For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com

Objetivos

1. Differentiate between the nine currently available classes of medications to treat diabetes.
2. Apply ADA and AACE practice guidelines for medication decision making.
3. Describe side effects and effectiveness used for treatment of diabetes mellitus.
4. Explain the use of combination therapy for treatment of chronic hyperglycemia.

Esquema

• Oral antihyperglycemics: alpha-glucosidase inhibitors, biguanides, DPP4-inhibitors, meglitinides, SGLT2 inhibitors, sulfonylureas, thiazolidinediones
• Injectable antihyperglycemics (not insulin): amylin analogs, incretin mimetics, GLP-1 agonists
• Insulins: rapid, regular, intermittent, long acting

• What has changed for 2022
• Standards of care and diagnosing
• Glycemic control algorithm
• Guidelines for monotherapy and combination therapy

• Medication decisions include side effects, organ effect, and adverse drug effects

• Insulin delivery systems: syringe, pen, pump, and inhaled insulin
• Algorithm for adding/intensifying insulin
• Patient education for storage, mixing and traveling
• Multiple daily injections vs. continuous glucose monitoring

Público objetivo

• Enfermeras
• Enfermeras especializadas
• Médicos
• Physicians Assistants